REYON Pharmaceutical Co., Ltd.
KSC: 102460.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Soon-Ock Jung
- Employees
- 448
- Headquarters
- Seoul, South Korea
- IPO year
- 2010
- Market cap
- ₩204.9B
- Website
- https://reyonpharm.co.kr
Loading 102460…
Loading profile data…Frequently asked questions about 102460
What does REYON Pharmaceutical Co., Ltd. (102460.KS) do?
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral...
Where does 102460.KS trade?
REYON Pharmaceutical Co., Ltd. (102460.KS) trades on the Korea Exchange.
What sector is 102460.KS in?
REYON Pharmaceutical Co., Ltd. (102460.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of REYON Pharmaceutical Co., Ltd.?
Soon-Ock Jung is the chief executive officer of REYON Pharmaceutical Co., Ltd. (102460.KS).
Where is REYON Pharmaceutical Co., Ltd. headquartered?
REYON Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 102460.KS pay a dividend?
Yes — REYON Pharmaceutical Co., Ltd. (102460.KS) paid a trailing twelve-month dividend of KRW 150.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 102460.KS go public?
REYON Pharmaceutical Co., Ltd. (102460.KS) completed its initial public offering in 2010.